This can be good for weight loss
Back De Herder, W, Klppel, G (28 July 2023) 'One hundred years after the discovery of insulin and glucagon: the history of tumors and hyperplasias that hypersecrete these hormones', Endocrine-Related Cancer , 30/9
But heres what really matters if youre dealing with type 2 diabetes (T2D) The REDEFINE 2 trial showed CagriSema achieving 13.7% weight loss vs 3.4% with placebo at 68 weeks in T2D patients
Both compounds are effective, and some patients achieve their goals successfully with semaglutide alone, while others benefit from the dual-action profile of tirzepatide
[94] Ornish D, Weidner G, Fair WR, et al
Audio transcript NINA MOINI: Starting next week, Medicare will begin a new pilot program that will allow some users to access popular weight loss drugs, GLP-1s, at a reduced cost